Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel in refractory partial seizures (OLE)
NCT00368472Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2006
- Primary completion
- Jun 2014
- Modality
- Classical Binding Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of perampanel in focal epilepsy, sponsored by Eisai Co., Ltd.. Started Oct 2006; status: completed.
02
Drugs
perampanel
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT00368472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368472.